An Evaluation of Treatment With Omalizumab to Improve the Asthmatic Response to an Experimental Infection With Rhinovirus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 04 Apr 2017 Planned number of patients changed from 42 to 22.
- 04 Apr 2017 Planned End Date changed from 1 Jun 2018 to 1 Jun 2017.
- 04 Apr 2017 Status changed from recruiting to active, no longer recruiting.